Keshavarzian A - Search Results

1

Longitudinal Survey of Microbiota in Hospitalized Preterm Very-Low-Birth-Weight Infants.

Patel AL, Mutlu EA, Sun Y, Koenig L, Green S, Jakubowicz A, Mryan J, Engen P, Fogg L, Chen AL, Pombar X, Meier PP, Keshavarzian A. Patel AL, et al. Among authors: keshavarzian a. J Pediatr Gastroenterol Nutr. 2016 Feb;62(2):292-303. doi: 10.1097/MPG.0000000000000913. J Pediatr Gastroenterol Nutr. 2016. PMID: 26230901 Free PMC article.

2

Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C.

Kennedy M, Bruninga K, Mutlu EA, Losurdo J, Choudhary S, Keshavarzian A. Kennedy M, et al. Among authors: keshavarzian a. Am J Gastroenterol. 2001 Apr;96(4):1080-4. doi: 10.1111/j.1572-0241.2001.03742.x. Am J Gastroenterol. 2001. PMID: 11316150 Clinical Trial.

3

New developments in the treatment of inflammatory bowel disease.

Mutlu EA, Farhadi A, Keshavarzian A. Mutlu EA, et al. Among authors: keshavarzian a. Expert Opin Investig Drugs. 2002 Mar;11(3):365-85. doi: 10.1517/13543784.11.3.365. Expert Opin Investig Drugs. 2002. PMID: 11866666 Review.

4

Intestinal permeation and gastrointestinal disease.

DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC. DeMeo MT, et al. Among authors: keshavarzian a. J Clin Gastroenterol. 2002 Apr;34(4):385-96. doi: 10.1097/00004836-200204000-00003. J Clin Gastroenterol. 2002. PMID: 11907349 Review.

5

Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide.

Farhadi A, Keshavarzian A, Fitzpatrick LR, Mutlu E, Zhang Y, Banan A. Farhadi A, et al. Among authors: keshavarzian a. Dig Dis Sci. 2002 Jun;47(6):1342-8. doi: 10.1023/a:1015382800434. Dig Dis Sci. 2002. PMID: 12064811

6

Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease.

Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ. Keshavarzian A, et al. Gut. 2003 May;52(5):720-8. doi: 10.1136/gut.52.5.720. Gut. 2003. PMID: 12692059 Free PMC article.

7

Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia.

Banan A, Farhadi A, Fields JZ, Mutlu E, Zhang L, Keshavarzian A. Banan A, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2003 Jul;306(1):13-28. doi: 10.1124/jpet.103.047415. J Pharmacol Exp Ther. 2003. PMID: 12815011

8

Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk.

Kaplan M, Mutlu EA, Jakate S, Bruninga K, Losurdo J, Losurdo J, Keshavarzian A. Kaplan M, et al. Among authors: keshavarzian a. Clin Gastroenterol Hepatol. 2003 Nov;1(6):433-7. doi: 10.1016/s1542-3565(03)00222-2. Clin Gastroenterol Hepatol. 2003. PMID: 15017642

9

Hyperalbuminemia and elevated transaminases associated with high-protein diet.

Mutlu EA, Keshavarzian A, Mutlu GM. Mutlu EA, et al. Among authors: keshavarzian a. Scand J Gastroenterol. 2006 Jun;41(6):759-60. doi: 10.1080/00365520500442625. Scand J Gastroenterol. 2006. PMID: 16716979

10

Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation.

Komanduri S, Gillevet PM, Sikaroodi M, Mutlu E, Keshavarzian A. Komanduri S, et al. Among authors: keshavarzian a. Clin Gastroenterol Hepatol. 2007 Mar;5(3):352-60. doi: 10.1016/j.cgh.2007.01.001. Clin Gastroenterol Hepatol. 2007. PMID: 17368235

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page